BioWorld

July 27, 2015

Early immunotherapy success in multiple myeloma

Multiple myeloma has joined the ranks of tumor types that show benefit from immunotherapy treatment, with early stage clinical results reported in the July 20, 2015, issue of Nature Medicine. Read More

Week in review

Word on the street

Week in Washington

American diabetes association’s scientific sessions: June 2015

American society of clinical oncology: June 2015

European hematology association: June 2015

Pharma clinical and FDA action update: June 2015

Money raised by biotech in 2015 vs. 2014

Money raised by biotech: Jan. 1 - July 23, 2015

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

BioWorld briefs for July 29, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for July 28, 2026

Illustration of dopamine signaling in the brain

New schizophrenia targets challenge trial design

BioWorld

The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...

AIDS 2026: New targets for metabolic dysfunction despite ART

BioWorld

Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...

Regulatory actions for July 27, 2026

BioWorld

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...